Keerthi Gogineni MD

Breast Cancer

Associate Professor at Emory School of Medicine

Emory Winship Cancer Institute1365C Clifton Road, Suite 4009Atlanta, GA 30322
Phone+1 404-778-5994
Fax+1 404-778-5530

Dr. Gogineni is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gogineni's full profile Already have an account?

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2007
University of Maryland School of MedicineClass of 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

GA State Medical License 2014 - 2027
PA State Medical License 2004 - 2016
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1) Start of enrollment: 2014 Jan 24
Completed
Phase 1
HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy Start of enrollment: 2014 Apr 08
COMPLETED
PHASE1
HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Start of enrollment: 2014 Oct 01
COMPLETED
PHASE1

Publications & Presentations

PubMed

1 citations
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
Robert Wesolowski, Hope S Rugo, Jennifer M Specht, Hyo S Han, Peter Kabos
Clinical Cancer Research. 2025-10-01
Association between travel burden and surgical timeliness for women with breast cancer in Georgia.
Nicole Rademacher, M Chandler McLeod, Courtney P Williams, Sofia Awan, Katherine E McElroy
American Journal of Surgery. 2025-09-01
4 citations
Awareness of the alcohol-breast cancer link among breast cancer survivors in the United States: a national cross-sectional survey.
Gaurav Seth, Vinitha Ganesan, Navneet Kaur, Sumayah Abed, Keerthi Gogineni
BMC Women's Health. 2025-07-18

Press Mentions

Safety and Efficacy of Extended Dosing Intervals of Denosumab in Patients with Solid Cancers and Bone Metastases: A Retrospective StudyDecember 23rd, 2020
Cold Caps to Fight Hair Loss from Chemotherapy: Will the Idea Catch on Here?April 24th, 2017
Survival Rates for Breast Cancer Differ for White, Black Women, Especially in AtlantaOctober 14th, 2016